Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment.
- R. Panos, R. Mortenson, S. Niccoli, T. King
- Medicine
- The American journal of medicine
- 1 April 1990
Patients with idiopathic pulmonary fibrosis (IPF) inevitably experience declines in functional status that are most frequently due to progressive pulmonary fibrosis. However, the cause of the… Expand
A Comprehensive Care Management Program to Prevent Chronic Obstructive Pulmonary Disease Hospitalizations
- V. Fan, J. Gaziano, +20 authors D. Niewoehner
- Medicine
- Annals of Internal Medicine
- 15 May 2012
BACKGROUND
Improving a patient's ability to self-monitor and manage changes in chronic obstructive pulmonary disease (COPD) symptoms may improve outcomes.
OBJECTIVE
To determine the efficacy of a… Expand
Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial.
- J. Stoller, R. Panos, S. Krachman, D. Doherty, B. Make
- Medicine
- Chest
- 1 July 2010
Long-term use of supplemental oxygen improves survival in patients with COPD and severe resting hypoxemia. However, the role of oxygen in symptomatic patients with COPD and more moderate hypoxemia at… Expand
Pulmonary hypertension associated with COPD
Although the prevalence of pulmonary hypertension (PH) in individuals with chronic obstructive pulmonary disease (COPD) is not known precisely, approximately 10%–30% of patients with moderate to… Expand
Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium.
- R. Panos, J. Rubin, K. Csaky, S. Aaronson, R. Mason
- Biology, Medicine
- The Journal of clinical investigation
- 1 August 1993
Epithelial-mesenchymal interactions mediate aspects of normal lung growth and development and are important in the restoration of normal alveolar architecture after lung injury. To determine if… Expand
Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.
- R. Panos, P. Bak, W. Simonet, J. Rubin, L. J. Smith
- Biology, Medicine
- The Journal of clinical investigation
- 1 October 1995
Alveolar type II cell proliferation occurs after many forms of lung injury and is thought to play a critical role in alveolar epithelial repair. Keratinocyte growth factor/fibroblast growth factor 7… Expand
Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis.
- A. Koch, M. M. Halloran, +8 authors N. Ferrara
- Medicine
- Arthritis and rheumatism
- 1 September 1996
OBJECTIVE
Angiogenesis is an integral component of the vasculoproliferative phase of rheumatoid arthritis (RA). Recently, a heparin-binding cytokine termed hepatocyte growth factor (HGF), or scatter… Expand
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.
BACKGROUND
Long-term treatment with supplemental oxygen has unknown efficacy in patients with stable chronic obstructive pulmonary disease (COPD) and resting or exercise-induced moderate… Expand
Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function.
Keratinocyte growth factor (KGF), also called fibroblast growth factor-7, is widely known as a paracrine growth and differentiation factor that is produced by mesenchymal cells and has been thought… Expand
Mediators, cytokines, and growth factors in liver-lung interactions.
Multiple mediators have been implicated in the interactions between the liver and the lungs in various disease states. The best characterized mediator of liver-lung interaction is alpha… Expand